Biallelic Germline BRCA1 Frameshift Mutations Associated with Isolated Diminished Ovarian Reserve
Authors:
- Anne Helbling-LeclercAHAnne Helbling-Leclerc
- Marie FalampinMFMarie Falampin
- Abdelkader HeddarAHAbdelkader Heddar
- Léa Guerrini-RousseauLGLéa Guerrini-Rousseau
- Maud MarchandMMMaud Marchand
- Iphigenie CavadiasICIphigenie Cavadias
- Nathalie AugerNANathalie Auger
- Brigitte Bressac-De PailleretsBPBrigitte Bressac-De Paillerets
- Laurence BrugieresLaurence Brugieres
- Bernard S. LopezBernard S. Lopez
- Michel PolakMPMichel Polak
- Filippo RosselliFRFilippo Rosselli
Open Access
- 20 November 2024
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 25 (22) , 12460
Abstract
The use of next-generation sequencing (NGS) has recently enabled the discovery of genetic causes of primary ovarian insufficiency (POI) with high genetic heterogeneity. In contrast, the causes of diminished ovarian reserve (DOR) remain poorly understood. Here, we identified by NGS and whole exome sequencing (WES) the cause of isolated DOR in a 14-year-old patient. Two frameshift mutations in BRCA1 (NM_007294.4) were found: in exon 8 (c.470_471del; p.Ser157Ter) and in exon 11 (c.791_794del, p.Ser264MetfsTer33). Unexpectedly, the patient presented no signs of Fanconi anemia (FA), i.e., no developmental abnormalities or indications of bone marrow failure. However, high chromosomal fragility was found in the patient’s cells, consistent with an FA diagnosis. RT-PCR and Western-blot analysis support the fact that the c. 791_794del BRCA1 allele is transcribed and translated into a shorter protein (del11q), while no expression of the full-length BRCA1 protein was found. DNA damage response (DDR) studies after genotoxic agents demonstrate normal activation of the early stages of the DDR and FANC/BRCA pathway. This is consistent with the maintenance of residual repair activity for the del11q BRCA1 isoform. Our observation is the first implication of bi-allelic BRCA1 mutations in isolated ovarian dysfunction or infertility in humans, without clinical signs of FA, and highlights the importance of BRCA1 in ovarian development and function.Keywords
Funding Information
- CNRS (PFS12-002)
- Université Paris-Saclay (PFS12-002)
- Hopitaux Universitaires Paris-Saclay (PFS12-002)
- Agence Nationale de Biomédecine (PFS12-002)
This publication has 63 references indexed in Scilit:
- The Frequency of Germline BRCA and Non-BRCA HR-Gene-Variants in a Cohort of Pancreatic Cancer PatientsDigestive Diseases and Sciences, 2022
- Primary ovarian insufficiency, meiosis and DNA repairBiomedical Journal, 2020
- Genotype-phenotype associations in Fanconi anemia: A literature reviewBlood Reviews, 2019
- Novel STAG3 mutations in a Caucasian family with primary ovarian insufficiencyMolecular Genetics and Genomics, 2019
- Biallelic germline BRCA1 mutations in a patient with early onset breast cancer, mild Fanconi anemia‐like phenotype, and no chromosome fragilityMolecular Genetics & Genomic Medicine, 2019
- Mutational spectrum in a worldwide study of 29,700 families withBRCA1orBRCA2mutationsHuman Mutation, 2018
- BRCA1 gene: function and deficiencyInternational Journal of Clinical Oncology, 2017
- Classification of the spliceogenic BRCA1 c.4096+3A>G variant as likely benign based on cosegregation data and identification of a healthy homozygous carrierClinical Case Reports, 2017
- Fanconi anemia and solid malignancies in childhood: A national retrospective studyPediatric Blood & Cancer, 2014
- Spanish family study on hereditary breast and/or ovarian cancer: Analysis of theBRCA1 geneInternational Journal of Cancer, 2000